Associate Director and Mass Spec Group Leader - Cell Engineering and Analytical Sciences, API-Proteins, J&J Innovative Medicines. Andrew began his career at J&J in 1997 and has continued his role in Mass Spectrometry for 26 years to support Innovative Medicine Discovery and Development.